New User:

Forgot your password?

Stock Market & Financial Investment News

News For CPHD;ISRG;FLDM From The Last 14 Days
Check below for free stories on CPHD;ISRG;FLDM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 23, 2014
09:16 EDTISRGOn The Fly: Pre-market Movers
Subscribe for More Information
09:00 EDTISRGIntuitive Surgical falls 9%
Intuitive Surgical is down 9%, or $37.83, to $384.50
07:41 EDTISRGIntuitive Surgical price target lowered to $443 from $490 at Leerink
Leerink lowered its price target for Intuitive Surgical shares to $443 citing low 2014 visibility after the company cut its procedure outlook. The firm keeps a Market Perform rating on the stock.
07:36 EDTISRGIntuitive Surgical price target lowered to $465 from $595 at Jefferies
Subscribe for More Information
07:34 EDTISRGIntuitive Surgical lowered 2014 procedure growth outlook to 2%-8%
Intuitive Surgical on its earnings conference call last night lowered its 2014 procedure growth guidance to 2%-8% from 9%-12%. The company said, "This is a wider range than we have previously communicated, giving consideration to increased volatility in elective procedures and the recent FDA statement discouraging the use of power morcellation techniques and the potential impact this may have on our procedure business."
April 22, 2014
17:24 EDTFLDMFluidigm upgraded to Buy from Neutral at Mizuho
Subscribe for More Information
16:14 EDTISRGIntuitive Surgical reports Q1 EPS with items $1.13, may not compare ests $3.27
Reports Q1 revenue $464.7M, consensus $507.04M. Q1 net income, including the $67M litigation accrual and reflecting the $26M revenue deferral associated with the da Vinci Xi customer trade-out program, was $44M, or $1.13 per diluted share, compared with $189M, or $4.56 per diluted share, for the prior year period.
15:57 EDTISRGIntuitive Surgical technical comments before results
Subscribe for More Information
13:15 EDTISRGEarnings Preview: Intuitive Surgical looks to rebound after Q1 preannouncement
Subscribe for More Information
08:35 EDTISRGIntuitive Surgical announces FDA clearance of da Vinci Sp Surgical System
Subscribe for More Information
April 17, 2014
17:39 EDTCPHDCepheid sees Q2 revenue $113M-$115M, consensus $110.68M.
Subscribe for More Information
16:10 EDTCPHDCepheid sees FY14 non-GAAP EPS 19c-24c, may not compare with consensus (24c)
Sees FY14 revenue in the range of $446M-$461M. Sees FY14 net loss in a range from $(0.43) to $(0.38) per share. Expected non-GAAP net income excludes approximately $33M related to stock compensation expense, approximately $9M related to the amortization of debt discount and debt issuance costs, and approximately $3M related to the amortization of acquired intangibles.
16:07 EDTCPHDCepheid reports Q1 non-GAAP EPS (1c), may not compare with consensus (17c)
Subscribe for More Information
15:29 EDTCPHDNotable companies reporting after market close
Notable companies reporting before tomorrow's market open, with earnings consensus, include athenahealth (ATHN), consensus 17c; Allison Transmission (ALSN), consensus 31c; Investors Bancorp (ISBC), consensus 24c; Cepheid (CPHD), consensus (17c); Advanced Micro Devices (AMD), consensus 0c; Associated Banc-Corp (ASBC), consensus 25c; Hub Group (HUBG), consensus 36c; Capital Bank (CBF), consensus 24c; Select Comfort (SCSS), consensus 32c; Acacia Research (ACTG), consensus 4c.
12:29 EDTISRGIntuitive Surgical lower after FDA discourages laparoscopic power morcellation
Subscribe for More Information
April 14, 2014
07:04 EDTFLDMFluidigm upgraded to Outperform from Market Perform at Leerink
Leerink upgraded Fluidigm to Outperform citing reasonable consensus revenue estimates and strong demand for single cell gene expression analysis tools. The firm has a $52 price target for shares.
06:30 EDTISRGIntuitive Surgical May volatility elevated at 41 on wide price movement
Intuitive Surgical May call option implied volatility is at 41, July is at 34; compared to its 26-week average 33.
April 11, 2014
08:51 EDTISRGLeerink's medical devices analysts hold an analyst/industry conference call
Subscribe for More Information
April 10, 2014
08:09 EDTISRGSurgeons positive on new Intuitive Surgical robot, says JPMorgan
JPMorgan said its survey of general surgeons indicated a positive reaction to Intuitive Surgical's recently approved da Vinci Xi system. The firm said many surgeons noted the multi-quadrant ability as a significant upgrade, which it notes should enable additional procedures. JPMorgan keeps an Overweight rating on Intuitive Surgical with a $550 price target.
07:03 EDTCPHDCepheid announces European release of Xpert Norovirus
Cepheid announced the release of Xpert Norovirus, a qualitative in vitro diagnostic test for rapid identification and differentiation of Noroviruses genogroup I and genogroup II, to be marketed as a CE IVD product under the European Directive on In Vitro Diagnostic Medical Devices. The test runs on Cepheid's GeneXpert System.
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use